Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896400 · ClinicalTrials.gov registry record · Phase 3
Optimizing Tobacco Dependence Treatment in the Emergency Department
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,056
- Enrollment target
NCT02896400 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 1,056 participants.
The verdict
NCT02896400, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,056 participants
- Enrollment target
Study Summary
The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-methods approach will be used to identify the components that were efficacious within the proposed cost constraint, along with feasibility and acceptability to providers and subjects. The investigators will then assemble an intervention that maximizes efficacy, given a cost-effectiveness constraint and findings from a qualitative analysis.
Interventions
- BEHAVIORAL Brief Negotiated Interview (BNI)
- DRUG Nicotine replacement therapy (NRT)
- OTHER CT Smokers Quitline (QL)
- OTHER SmokefreeText (Text)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,056 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2019-08-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02896400
The ClinicalTrials.gov registry entry for NCT02896400 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,056 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Brief Negotiated Interview (BNI) is the first listed.
NCT02896400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02896400 about?
NCT02896400 is a clinical study titled "Optimizing Tobacco Dependence Treatment in the Emergency Department". The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-m...
What is the current status of trial NCT02896400?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,056 participants. The study started on 2017-02-13. Estimated completion is 2019-08-14.
What interventions are being tested in trial NCT02896400?
The interventions under investigation include: Brief Negotiated Interview (BNI) (BEHAVIORAL), Nicotine replacement therapy (NRT) (DRUG), CT Smokers Quitline (QL) (OTHER), SmokefreeText (Text) (OTHER).
Who is sponsoring clinical trial NCT02896400?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.